Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098423
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2004-12-07
Brief Title:
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia or Myelodysplastic Syndromes
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2004-12-07
First Submit QC Date:
December 7 2004
Study First Post Date:
2004-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-27
Last Update Post Date:
2013-09-30
Last Update Post Date Type:
ESTIMATED